Incidental Prostate Cancer: A Real Need for Expansion in Guidelines?

Mottet, Nicolas; Rouvière, Olivier

doi:10.1016/j.euo.2021.04.006

European Urology Oncology

2022

DOI: 10.1016/j.euo.2021.04.006

|View full text |Cite

Incidental Prostate Cancer: A Real Need for Expansion in Guidelines?

Nicolas Mottet

Olivier Rouvière

Abstract: Referring to the article published on pp. x-y of this issue

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

2024

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 5 publications

(1 citation statement)

References 8 publications

(10 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Changes in PSA value and abnormal digital rectal examination (nodules and stiffness) are the findings that lead the patient to biopsy. [ 3 ] Transrectal finger-guided needle prostate biopsy has evolved into the present form with Takahashi et al using ultrasound in the field of urology and 1989 by Hodge et al reporting a TRUS-guided sextant biopsy. [ 4 , 5 ] At present, TRUS-guided 10–12 quadrant prostate biopsy is considered the gold standard.…”

mentioning

confidence: 99%

Comparison of Transrectal Ultrasonography-Guided Prostate Biopsies Analgesia’s; Rectal Lidocaine Gel Versus Sandwich Anesthesia (Transurethral Plus Transrectal Lidocaine Gel Administration): A Double-Blind, Randomized, Controlled and Prospective Study

Turkmen

2023

Sisli Etfal

View full text Add to dashboard Cite

Objectives We aimed to evaluate the effectiveness of the additive transurethral anesthetic agent to transrectal anesthetic agent. Methods Transrectal ultrasound-guided 12 core prostate biopsy planned, 237 patients included in our study. The patients randomly divided into two groups. Group 1 (n=113): Only transrectal 2% lidocaine, Group 2 (n=124): Transrectal + Transurethral(Sandwiches) lidocaine gel given to the patients 10 min before the procedure as anesthesia. Immediately after the biopsy, the patient questioned about the level of pain he felt during the needle entry. The evaluation measured by the VAS score. Immediately after biopsy satisfaction rate with the procedure and if rebiopsy was required, acceptance was scored between 1 and 4. The two groups compared statistically. Results The mean VAS score of Group 1 and Group 2 was 4.88±1.89 and 3.77±1.83, respectively. The pain level of Group 2 was lower than Group 1’ pain level. The difference between the two groups was considered statistically significant (p<0.001). The patient satisfaction rates of Group 1 and Group 2 found to be 2.45±0.71 and 2.78±0.66, and the acceptance rate of rebiopsy was 2.81±0.69 and 3.02±0.51, respectively. The patient satisfaction rate and acceptance rate of the rebiopsy of Group 2 were higher than Group 1. Patient satisfaction level (p<0.001) and rebiopsy acceptance rate (p=0.014) between the two groups found to be statistically significant. Conclusion In the TRUS-guided prostate biopsies, sandwich anesthesia is a cheap, convenient, tolerable, and effective method.

show abstract

mentioning

confidence: 99%

Comparison of Transrectal Ultrasonography-Guided Prostate Biopsies Analgesia’s; Rectal Lidocaine Gel Versus Sandwich Anesthesia (Transurethral Plus Transrectal Lidocaine Gel Administration): A Double-Blind, Randomized, Controlled and Prospective Study

Turkmen

2023

Sisli Etfal

View full text Add to dashboard Cite

show abstract

Prevalence and potential predictors of incidental prostate Cancer in patients undergoing surgery for Benign Prostatic obstruction: a retrospective study in the MRI era

Esperto,

Cacciatore,

Tedesco

et al. 2024

World J Urol

View full text Add to dashboard Cite

Reply to Nicolas Mottet, Olivier Rouviere, and Theodorus H. van der Kwast. Incidental Prostate Cancer: A Real Need for Expansion in Guidelines? Eur Urol Oncol. In press

Capitanio

Autorino

Bandini

et al. 2021

European Urology Oncology

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Incidental Prostate Cancer: A Real Need for Expansion in Guidelines?

Abstract: Referring to the article published on pp. x-y of this issue

Cited by 5 publications

References 8 publications

Comparison of Transrectal Ultrasonography-Guided Prostate Biopsies Analgesia’s; Rectal Lidocaine Gel Versus Sandwich Anesthesia (Transurethral Plus Transrectal Lidocaine Gel Administration): A Double-Blind, Randomized, Controlled and Prospective Study

Comparison of Transrectal Ultrasonography-Guided Prostate Biopsies Analgesia’s; Rectal Lidocaine Gel Versus Sandwich Anesthesia (Transurethral Plus Transrectal Lidocaine Gel Administration): A Double-Blind, Randomized, Controlled and Prospective Study

Prevalence and potential predictors of incidental prostate Cancer in patients undergoing surgery for Benign Prostatic obstruction: a retrospective study in the MRI era

Reply to Nicolas Mottet, Olivier Rouviere, and Theodorus H. van der Kwast. Incidental Prostate Cancer: A Real Need for Expansion in Guidelines? Eur Urol Oncol. In press

Contact Info

Product

Resources

About